Cromsource, an international contract research organisation providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced on Tuesday that it has appointed David R. Dills as new director of its Regulatory Services Department .

Dills has more than 28 years of experience in the medical device and pharmaceutical industry. He has held positions of increasing responsibility with sponsor and service companies of various sizes, including large, global OEM's/sponsors, consultancies and a global CROs and virtual, small, mid and large-sized enterprises and has serviced sponsors and clients in multiple global locations.

Speaking of the appointment, Dr Margherita Mosconi, the company's chief services officer, said: "Whatever the stage of clinical development, our clients need a partner that can provide the global regulatory capabilities to support their product portfolio for commercial success. His tremendous broad experience will support CROMSOURCE in expanding its services into strategic regulatory consultation to biotechnology Companies."